A paradigm shift in molecular biology has set in. It is now possible to email a DNA sequence to a company and receive a recombinant plasmid vector of choice. We are soon heading into an era where ...

Sponsored content brought to you by Success in gene and cell therapy is driving demand for plasmid DNA which is a key reagent to produce viral vectors, both for commercial products as well as the ...

Cutting-edge centrifugation technology streamlines bacterial harvesting, DNA purification, and RNA synthesis for high-volume ...

In the development of DNA vaccines and cell and gene therapies, manufacturing plasmid DNA creates a crucial bottleneck. Such a slowdown could intensify with the market for manufacturing DNA ...

The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected to reach around USD 46.02 billion by 2034, growing at a CAGR of 20.4% ...

This plasmid vector is important for transferring genes that confer host benefits, like the capacity to manufacture unique proteins or antibiotic resistance. What a DNA Plasmid Entails DNA plasmid ...

A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are encapsulated into recombinant adeno-associated virus (rAAV) capsids as single ...

This created a recombinant DNA molecule—a plasmid containing recombined DNA from two different sources. Next, they inserted the plasmid into bacteria and demonstrated that the bacteria could use the ...

The global viral vector & plasmid DNA manufacturing market size is expected to reach USD 882.9 million by 2025, rising at a 16.0% CAGR during the forecast period.

Plasmid DNA encoding the luciferase reporter gene was complexed with the cationic lipid GL67 and delivered to the mouse airways.